SEC Form 5 · accession 0001432453-15-000019
Neurokine Pharmaceuticals Inc. · BETRF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ahmad Doroudian
Officer — Chairman · Director
Period of report
Jan 31, 2014
Accepted (ET)
Mar 10, 2015 · 3:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001464165
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF2 | Sep 24, 2013 | P$0 | 35,000,000 | $0.00 | A | 37,469,784 | D | |
| Common Shares | holding | — | — | — | 2,469,784 | D | ||
| Common Shares | holding | — | — | — | 2,000,000 | I | owned by spouse | |
| Common SharesF1 | holding | — | — | — | 2,000,000 | I | owned by Kinwa Pharma International Company Ltd. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $0.005 | holding | — | — | — | May 25, 2010 | May 25, 2015 | Common Shares | 800,000 | 800,000 | D |
| Warrants | $0.005 | holding | — | — | — | Jul 30, 2010 | Jul 29, 2015 | Common Shares | 500,000 | 500,000 | D |
Explanation of responses
- F1Kinwa Pharma International Company Ltd. is a company over which Dr. Ahmad Doroudian and his spouse have shared voting and investment power.
- F2Acquisition of shares through settlement of debts (deemed price of $0.001)